drugset / Trial / NCT00431444
Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will compare the effects of Zoledronic acid and Raloxifene in reducing bone turnover markers in postmenopausal women with low bone mineral density over 6 months.
Timeline
- Start
- 2007-01
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Raloxifene | Other / unclassified | 60 mg | Oral |
| Comparator | Zoledronic acid | Other / unclassified | 5 mg | Intravenous |